Cargando…
New Sorafenib Derivatives: Synthesis, Antiproliferative Activity Against Tumour Cell Lines and Antimetabolic Evaluation
Sorafenib is a relatively new cytostatic drug approved for the treatment of renal cell and hepatocellular carcinoma. In this report we describe the synthesis of sorafenib derivatives 4a–e which differ from sorafenib in their amide part. A 4-step synthetic pathway includes preparation of 4-chloropyri...
Autores principales: | Babić, Željka, Crkvenčić, Maja, Rajić, Zrinka, Mikecin, Ana-Matea, Kralj, Marijeta, Balzarini, Jan, Petrova, Mariya, Vanderleyden, Jos, Zorc, Branka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6268433/ https://www.ncbi.nlm.nih.gov/pubmed/22269830 http://dx.doi.org/10.3390/molecules17011124 |
Ejemplares similares
-
Primaquine and Chloroquine Fumardiamides as Promising Antiplasmodial Agents
por: Beus, Maja, et al.
Publicado: (2019) -
The novel amidocarbamate derivatives of ketoprofen: synthesis and biological activity
por: Rajić, Zrinka, et al.
Publicado: (2010) -
Synthesis and Biological Evaluation of Harmirins, Novel Harmine–Coumarin Hybrids as Potential Anticancer Agents
por: Pavić, Kristina, et al.
Publicado: (2021) -
Primaquine derivatives: Modifications of the terminal amino group
por: Zorc, Branka, et al.
Publicado: (2019) -
Antiproliferative and antimetabolic effects behind the anticancer property of fermented wheat germ extract
por: Otto, Christoph, et al.
Publicado: (2016)